This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
2mg | $250 | To Be Confirmed |
5mg | $450 | To Be Confirmed |
10mg | $750 | To Be Confirmed |
25mg | $1250 | To Be Confirmed |
50mg | $1950 | To Be Confirmed |
100mg | $3250 | To Be Confirmed |
Cat #: V10251 CAS #: 1229453-99-9 Purity ≥ 98%
Description: Acrizanib, formerly known as LHA510, is a novel, potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 445.4062 |
---|---|
Molecular Formula | C20H18F3N7O2 |
CAS No. | 1229453-99-9 |
Synonyms | Acrizanib; LHA510; LHA 510; LHA-510. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.2451 mL | 11.2257 mL | 22.4514 mL | 44.9028 mL |
5mM | 0.4490 mL | 2.2451 mL | 4.4903 mL | 8.9806 mL |
10mM | 0.2245 mL | 1.1226 mL | 2.2451 mL | 4.4903 mL |
20mM | 0.1123 mL | 0.5613 mL | 1.1226 mL | 2.2451 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.